Quantcast

Industry news that matters to you.  Learn more

MolecularMatch Announces Innovative Solution to Connect Cancer Patients with the Most Effective Treatments and Clinical Trials

MolecularMatch, Inc. recently announced it has launched its innovative software solution as an open Beta information service for oncologists and patients to easily connect cancer patients with the most appropriate FDA-approved treatments and clinical trials based on the molecular make-up of the patient’s disease.

Definiens Signs Agreement with Clarient to Offer Validated Solutions for Routine Clinical Pathology Testing

Definiens, the global leader in image analysis for digital pathology and diagnostics recently announced the signing of an agreement with Clarient Diagnostic Services, Inc.- which extends the use of Definiens’ automated image analysis software and solutions in Clarient’s validated clinical applications for immunohistochemistry testing in breast cancer. Definiens’ proprietary Cognition Network Technology® is core to automatically classify and quantitate key tissue features as part of Clarient’s Scope IA Platform offering to its pathology customers.

Rancho BioSciences Partners with OmicSoft for Manual Data Curation

Rancho BioSciences, the leading manual data curation company for genomic and clinical data recently announced that they will partner with OmicSoft, an industry leading provider of enterprise solutions for next-generation sequencing and Omics data analysis, management, and visualization. Rancho BioSciences and OmicSoft will collaborate on customer driven projects to curate data in order to make it analysis ready, leveraging Rancho BioSciences global team of PhD and MD curators and OmicSoft tools and databases for biomarker data management, visualization, and analysis. OmicSoft software is powerful but easy to use, allowing the bench scientist, bioinformatician and statistician to all benefit from the same tools.

Gentris Corporation Launches Next Generation Human Transcriptome Array

Gentris Corporation (www.gentris.com), a global leader in pharmacogenomics and biorepository solutions, recently announced that it is expanding its genomic biomarker offering with the launch of Affymetrix GeneChip(R) Human Transcriptome Array (HTA) services. The GeneChip(R) HTA is a high resolution microarray for gene expression that is designed to empower next-generation expression profiling studies. The new array goes beyond gene-level expression profiling by providing the coverage and accuracy required to detect all known transcript isoforms produced by a gene.

Definiens and Advanced Cell Diagnostics Launch Software for Quantitative RNA In Situ Hybridization

Definiens AG, a healthcare company that advances personalized medicine through image analysis and digital pathology solutions, and Advanced Cell Diagnostics (ACD) of Hayward California, a leader in molecular pathology, announced recently the commercial launch of RNAscope® SpotStudio™, a custom-designed image analysis software application for ACD’s RNAscope®Assays to detect and quantify RNA biomarkers. By combining state-of-the-art image analysis and advanced in situ hybridization technologies, gene expression can be measured quantitatively at single cell resolution and interpreted by pathologists within context.